EMILY BRAUN: Open Payments
NPI 1023574043 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,824 in 117 payments from 17 companies in 2025. Trend: 2023 $3,778 · 2024 $3,701 · 2025 $2,824
Food & beverage: $2,769Education: $55
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $660 |
| Janssen Biotech, Inc. | 15 | $509 |
| Galderma Laboratories, L.P. | 23 | $419 |
| GENZYME CORPORATION | 9 | $263 |
| Novartis Pharmaceuticals Corporation | 17 | $252 |
| Lilly USA, LLC | 13 | $191 |
| UCB, Inc. | 1 | $125 |
| Amgen Inc. | 3 | $76 |
| LEO Pharma Inc. | 3 | $55 |
| Arcutis Biotherapeutics, Inc. | 2 | $51 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, NEMLUVIO, RINVOQ, TALTZ, AKLIEF.
Industry payments across NY — which companies pay providers there.
